ID NPFF_HUMAN STANDARD; PRT; 113 AA. AC O15130; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1998, sequence version 1. DT 04-APR-2006, entry version 42. DE FMRFamide-related peptides precursor [Contains: Neuropeptide SF DE (NPSF); Neuropeptide FF (NPFF); Neuropeptide AF (NPAF)]. GN Name=NPFF; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Testis; RX MEDLINE=97367936; PubMed=9224703; DOI=10.1016/S0014-5793(97)00557-7; RA Perry S.J., Yi-Kung Huang E., Cronk D., Bagust J., Sharma R., RA Walker R.J., Wilson S., Burke J.F.; RT "A human gene encoding morphine modulating peptides related to NPFF RT and FMRFamide."; RL FEBS Lett. 409:426-430(1997). RN [2] RP FUNCTION. RX PubMed=11587714; DOI=10.1016/S0028-3908(01)00107-1; RA Catarsi S., Babinski K., Seguela P.; RT "Selective modulation of heteromeric ASIC proton-gated channels by RT neuropeptide FF."; RL Neuropharmacology 41:592-600(2001). CC -!- FUNCTION: Morphine modulating peptides. Have wide-ranging CC physiologic effects, including the modulation of morphine-induced CC analgesia, elevation of arterial blood pressure, and increased CC somatostatin secretion from the pancreas. Neuropeptide FF CC potentiates and sensitizes ACCN2 and ACCN3 channels. CC -!- SUBCELLULAR LOCATION: Secreted protein. CC -!- SIMILARITY: Belongs to the FARP (FMRFamide related peptide) CC family. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF005271; AAB64288.1; -; mRNA. DR UniGene; Hs.104555; -. DR Ensembl; ENSG00000139574; Homo sapiens. DR HGNC; HGNC:7901; NPFF. DR MIM; 604643; gene. DR GO; GO:0005625; C:soluble fraction; TAS. DR GO; GO:0005102; F:receptor binding; TAS. DR GO; GO:0007218; P:neuropeptide signaling pathway; TAS. DR GO; GO:0007268; P:synaptic transmission; TAS. DR InterPro; IPR008065; FMRFamid_rel_pep. DR PANTHER; PTHR15044; FMRFamid_rel_pep; 1. DR PRINTS; PR01682; FMRFAMIDEPEP. KW Amidation; Cleavage on pair of basic residues; Neuropeptide; Signal. FT SIGNAL 1 20 Potential. FT PROPEP 21 65 FT /FTId=PRO_0000009898. FT PEPTIDE 66 76 Neuropeptide SF. FT /FTId=PRO_0000009899. FT PEPTIDE 69 76 Neuropeptide FF. FT /FTId=PRO_0000009900. FT PROPEP 79 92 FT /FTId=PRO_0000009901. FT PEPTIDE 93 110 Neuropeptide AF. FT /FTId=PRO_0000009902. FT MOD_RES 76 76 Phenylalanine amide (G-77 provides amide FT group). FT MOD_RES 110 110 Phenylalanine amide (G-111 provides amide FT group). SQ SEQUENCE 113 AA; 12440 MW; 1E9D4ED2A69238E3 CRC64; MDSRQAAALL VLLLLIDGGC AEGPGGQQED QLSAEEDSEP LPPQDAQTSG SLLHYLLQAM ERPGRSQAFL FQPQRFGRNT QGSWRNEWLS PRAGEGLNSQ FWSLAAPQRF GKK //